Louie Ngar Yee - Oct 2, 2025 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Director
Signature
/s/ Louie Ngar Yee
Stock symbol
MAIA
Transactions as of
Oct 2, 2025
Transactions value $
$0
Form type
4
Date filed
10/6/2025, 04:24 PM
Previous filing
Jul 2, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Louie Ngar Yee Director 444 WEST LAKE STREET, SUITE 1700, CHICAGO /s/ Louie Ngar Yee 2025-10-06 0001913264

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MAIA Stock Options Award $0 +25.3K $0.00 25.3K Oct 2, 2025 Common Stock 25.3K $1.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options, granted on October 2, 2025, pursuant to the MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.